These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23648652)

  • 1. Adherence associated with oral medications in the treatment of spasticity.
    Halpern R; Gillard P; Graham GD; Varon SF; Zorowitz RD
    PM R; 2013 Sep; 5(9):747-56. PubMed ID: 23648652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
    Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
    Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Patel DR; Soyode O
    Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Vakhapova V; Auriel E; Karni A
    Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral baclofen and clonidine for treatment of spasticity in children.
    Lubsch L; Habersang R; Haase M; Luedtke S
    J Child Neurol; 2006 Dec; 21(12):1090-2. PubMed ID: 17156708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs used to treat spasticity.
    Kita M; Goodkin DE
    Drugs; 2000 Mar; 59(3):487-95. PubMed ID: 10776831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrathecal baclofen in the treatment of severe spastic tetraplegia and dystonia in children and adolescents].
    Illum NO; Hansen FJ; Fischer C; Uldall PV; Nielsen OA
    Ugeskr Laeger; 2003 Apr; 165(17):1755-9. PubMed ID: 12768902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
    Borah B; Sacco P; Zarotsky V
    Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
    Stokic DS; Yablon SA; Hayes A
    Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
    Harned ME; Salles SS; Grider JS
    Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.